<DOC>
	<DOCNO>NCT02434640</DOCNO>
	<brief_summary>The objective trial investigate safety tolerability BAY1128688 determine concentration substance blood repeat administration oral route . The investigational substance administer tablet form healthy woman .</brief_summary>
	<brief_title>Ascending Dose Study Investigate Safety , Tolerability Pharmacokinetics BAY1128688 After Multiple Oral Administrations Healthy Women</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<criteria>PART A Postmenopausal state , reveal 1 . Medical history . One following : Natural menopause least 12 month prior first study drug administration , Surgical menopause bilateral ovariectomy least 3 month prior first study drug administration ) Hysterectomy AND 2 . Folliclestimulating hormone ( FSH ) &gt; 40 IU/L Age 45 68 year PART B Healthy female subject Sterilized tuballigation Pretreatment menstrual cycle assess ovulatory Completion 3 menstrual cycle delivery , abortion lactation Age 18 48 year Body mass index ( kg/m2 ) great equal 32 ( less equal 18 ) Smoking : PART A : nonsmoking ; PART B : le 10 cigarette per day Use medicine include restricted contraceptive NSAIDs ( detail regard previous use medicine provide study center ) Ability willingness adhere restriction regard diet ( PART A B ) eat standardise meal ( PART A ) Significant diseases heart , gastrointestinal tract and/or liver and/or kidney and/or reproductive organ ( present past ; detail provide study center ) Recent infectious disease ( detail provide study center ) Migraine depression Thyroid disease require treatment Metabolic disorder , example diabetes mellitus hypertriglyceridemia Drug alcohol abuse ; regular consumption 800 ml beer per day ( drink resemble 40 g alcohol )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>